NovoCure (NVCR) Share-based Compensation Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.28% |
| Dec 31, 2025 | -0.45% |
| Sep 30, 2025 | 7.82% |
| Jun 30, 2025 | 6.85% |
| Mar 31, 2025 | 12.28% |
| Dec 31, 2024 | 33.69% |
| Sep 30, 2024 | 16.95% |
| Jun 30, 2024 | 18.31% |
| Mar 31, 2024 | 28.71% |
| Dec 31, 2023 | 10.38% |
| Sep 30, 2023 | 20.25% |
| Jun 30, 2023 | 26.25% |
| Mar 31, 2023 | 35.62% |
| Dec 31, 2022 | 36.19% |
| Sep 30, 2022 | 24.97% |
| Jun 30, 2022 | 27.82% |
| Mar 31, 2022 | 40.58% |
| Dec 31, 2021 | 36.53% |
| Sep 30, 2021 | 35.56% |
| Jun 30, 2021 | 37.67% |
| Mar 31, 2021 | 28.16% |
| Dec 31, 2020 | 35.20% |
| Sep 30, 2020 | 47.03% |
| Jun 30, 2020 | 48.13% |
| Mar 31, 2020 | 55.66% |
| Dec 31, 2019 | 63.19% |
| Sep 30, 2019 | 64.10% |